Airport Technology 

The Centers for Disease Control and Prevention (CDC) in the US has extended its collaboration with XpresSpa Group’s subsidiary XpresCheck for the Covid-19 biosurveillance programme at airports.

The extension increases the contract value from the initial level of $2m to $5.6m.

The Covid-19 biosurveillance programme was initially introduced in September last year.

Full Report

Not a member?
Take a look at our member benefits